{{Rsnum
|rsid=4712524
|Gene=CDKAL1
|Chromosome=6
|position=20657634
|Orientation=plus
|GMAF=0.4091
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=CDKAL1
}}{{PMID Auto GWAS
|PMID=18711366
|Trait=Type 2 diabetes
|Title=SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations
|RiskAllele=G
|Pval=3E-10
|OR=1.22
|ORtxt=[1.15-1.31]
}}

{{PharmGKB
|RSID=rs4712524
|Name_s=
|Gene_s=CDKAL1
|Feature=
|Evidence=PubMed ID:18711366; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. (Initial Sample Size: 194 Japanese cases, 1,558 Japanese controls; Replication Sample Size: 4,924 cases, 2,618 controls (Japanese), 1433 cases, 1,735 controls (Singaporean), 3,891 cases, 4,888 controls (Danish)); (Region: 6p22.3; Reported Gene(s): CDKAL1; Risk Allele: rs4712524-G); (p-value= 0.0000000003).This variant is associated with Type 2 diabetes.
|Drugs=
|Drug Classes=
|Diseases=Diabetes Mellitus; Diabetes Mellitus, Type 2
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740857
}}

{{PMID Auto
|PMID=22437209
|Title=Genetic variants on chromosome 6p21.1 and 6p22.3 are associated with type 2 diabetes risk: a case-control study in Han Chinese
}}
{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs4712524
|overall_frequency_n=60
|overall_frequency_d=128
|overall_frequency=0.46875
|n_genomes=40
|n_genomes_annotated=0
|n_haplomes=53
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}